PULSE BIOSCIENCES, INC. — Director's Dealing 2023

Jul 8, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-07-05

Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-07-05	Common Stock	M	65000	$2.14	Acquired	36162824	Direct
2023-07-07	Common Stock	M	65467	$2.14	Acquired	36228291	Direct
2023-07-07	Common Stock	M	1666	$5.95	Acquired	36229957	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-05	Stock Option (right to buy)	$2.14	M	65000	Disposed	2032-05-19	Common Stock (65000)	Direct
2023-07-07	Stock Option (right to buy)	$2.14	M	65467	Disposed	2032-05-19	Common Stock (65467)	Direct
2023-07-07	Stock Option (right to buy)	$5.95	M	1666	Disposed	2033-05-25	Common Stock (1666)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	492069	Indirect

Footnotes

F1: Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.

F2: All of the shares subject to the option are fully vested and exercisable as of the date hereof.

F3: Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vests on a monthly basis following the Company's last Annual Stockholder Meeting.